Literature DB >> 1987062

Differential expression of Trypanosoma cruzi neuraminidase in intra- and extracellular trypomastigotes.

I A Rosenberg1, R P Prioli, J S Mejia, M E Pereira.   

Abstract

The developmentally regulated expression of Trypanosoma cruzi neuraminidase in culture cells was monitored by immunofluorescence with a monoclonal antibody (TCN-2) against the enzyme. The results showed that TCN-2 reacted with all intracellular trypomastigote forms (NA+) but not with amastigotes. Immunoprecipitation of radiolabeled neuraminidase confirmed TCN-2 reactivity with trypomastigotes and the specificity of the antibody binding. During exiting from the host cells, all trypomastigotes were still NA+. However, when free in the extracellular environment, the relative proportion of NA+ parasites declined from 100% to about 20%, thereby establishing a subpopulation of trypomastigotes which did not express enzyme (NA-). The expression of neuraminidase in all intracellular trypomastigotes and in only a subpopulation of the extracellular counterpart suggests that the enzyme may play a role in parasite exiting from infected cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987062      PMCID: PMC257767          DOI: 10.1128/iai.59.1.464-466.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Heterogeneous distribution of neuraminidase activity in strains and clones of Trypanosoma cruzi and its possible association with parasite myotropism.

Authors:  M E Pereira; R Hoff
Journal:  Mol Biochem Parasitol       Date:  1986-08       Impact factor: 1.759

Review 2.  Structure and diversity of influenza virus neuraminidase.

Authors:  P M Colman; C W Ward
Journal:  Curr Top Microbiol Immunol       Date:  1985       Impact factor: 4.291

3.  Monoclonal antibodies against Trypanosoma cruzi neuraminidase reveal enzyme polymorphism, recognize a subset of trypomastigotes, and enhance infection in vitro.

Authors:  R P Prioli; J S Mejia; M E Pereira
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

4.  A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells.

Authors:  P Libby; J Alroy; M E Pereira
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

5.  The genetic basis of antibody production: the dominant anti-arsonate idiotype response of the strain A mouse.

Authors:  M Siekevitz; M L Gefter; P Brodeur; R Riblet; A Marshak-Rothstein
Journal:  Eur J Immunol       Date:  1982-12       Impact factor: 5.532

6.  A developmentally regulated neuraminidase activity in Trypanosoma cruzi.

Authors:  M E Pereira
Journal:  Science       Date:  1983-03-25       Impact factor: 47.728

7.  Studies of Trypanosoma cruzi clones in inbred mice. I. A comparison of the course of infection of C3H/HEN- mice with two clones isolated from a common source.

Authors:  M Postan; J A Dvorak; J P McDaniel
Journal:  Am J Trop Med Hyg       Date:  1983-05       Impact factor: 2.345

8.  Serum neuraminidase activity and hematological alterations in acute human Chagas' disease.

Authors:  E H de Titto; F G Araujo
Journal:  Clin Immunol Immunopathol       Date:  1988-01

9.  Antibody to Trypanosoma cruzi neuraminidase enhances infection in vitro and identifies a subpopulation of trypomastigotes.

Authors:  R Cavallesco; M E Pereira
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

  9 in total
  7 in total

1.  The Trypanosoma cruzi neuraminidase contains sequences similar to bacterial neuraminidases, YWTD repeats of the low density lipoprotein receptor, and type III modules of fibronectin.

Authors:  M E Pereira; J S Mejia; E Ortega-Barria; D Matzilevich; R P Prioli
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

2.  Invasive phenotype of Trypanosoma cruzi restricted to a population expressing trans-sialidase.

Authors:  M E Pereira; K Zhang; Y Gong; E M Herrera; M Ming
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

3.  Trypanosoma cruzi targets Akt in host cells as an intracellular antiapoptotic strategy.

Authors:  Marina V Chuenkova; Mercio PereiraPerrin
Journal:  Sci Signal       Date:  2009-11-17       Impact factor: 8.192

4.  Stage-specific expression and intracellular shedding of the cell surface trans-sialidase of Trypanosoma cruzi.

Authors:  U Frevert; S Schenkman; V Nussenzweig
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 5.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

Review 6.  On the interaction of Trypanosoma cruzi neuraminidase and human lipoproteins.

Authors:  R P Prioli; J S Mejia; M E Pereira
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

7.  Sera from chronic Chagasic patients and rodents infected with Trypanosoma cruzi inhibit trans-sialidase by recognizing its amino-terminal and catalytic domain.

Authors:  V L Pereira-Chioccola; S Schenkman; J K Kloetzel
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.